Palonosetron Hydrochloride/Aprepitant

盐酸帕洛诺司琼/阿瑞匹坦

Report date: 2025/12/16 17:30:42

Base Information

Drug NamePalonosetron Hydrochloride/Aprepitant
Drug Alias NameQLM2010QLM-2010
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonistsNeurokinin 1 receptor antagonists
TargetsSerotonin 3 (5-HT3) receptorNeurokinin 1 receptor
Therapy Area/IndicationsChemotherapy-induced nausea and vomiting
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Palonosetron HydrochlorideAprepitant
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesQilu Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQilu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsChemotherapy-induced nausea and vomiting
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A